搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

  1. 首頁(yè)
  2. 試劑盒
  3. 酶聯(lián)免疫試劑盒
  4. Human Metastasis-associated in colon cancer protein 1(MACC1) ELISA kit

Human Metastasis-associated in colon cancer protein 1(MACC1) ELISA kit

  • 中文名稱：
    人結(jié)腸癌病灶轉(zhuǎn)移相關(guān)蛋白1(MACC1)酶聯(lián)免疫試劑盒
  • 貨號(hào)：
    CSB-EL013298HU
  • 規(guī)格：
    96T/48T
  • 價(jià)格：
    ￥3600/￥2500
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    人結(jié)腸癌病灶轉(zhuǎn)移相關(guān)蛋白1(MACC1)酶聯(lián)免疫試劑盒（CSB-EL013298HU）為雙抗夾心法ELISA試劑盒，定量檢測(cè)血清、血漿、組織勻漿、細(xì)胞裂解物樣本中的MACC1含量。MACC1（結(jié)腸癌轉(zhuǎn)移相關(guān)基因1）是一種在多種腫瘤中表達(dá)異常升高的基因，與腫瘤轉(zhuǎn)移和患者預(yù)后密切相關(guān)。其研究機(jī)制主要涉及維持腫瘤相關(guān)信號(hào)活性、轉(zhuǎn)錄激活促癌基因、調(diào)控上皮間質(zhì)轉(zhuǎn)化和促進(jìn)腫瘤血管形成等方面。MACC1的表達(dá)受非編碼RNA和SNP等調(diào)控，有望成為抗腫瘤治療的新靶點(diǎn)。試劑盒檢測(cè)范圍為47 pg/mL-3000 pg/mL，適用于基礎(chǔ)醫(yī)學(xué)研究中腫瘤標(biāo)志物表達(dá)分析、癌癥轉(zhuǎn)移相關(guān)信號(hào)通路探索、藥物干預(yù)效果評(píng)估等場(chǎng)景，為科研人員探究MACC1在腫瘤進(jìn)展中的作用機(jī)制提供標(biāo)準(zhǔn)化工具本品僅用于科研，不用于臨床診斷，產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書。
  • 別名：
    7A5 ELISA Kit; MACC1 ELISA Kit; MACC1_HUMAN ELISA Kit; Metastasis associated in colon cancer 1 ELISA Kit; Metastasis-associated in colon cancer protein 1 ELISA Kit; OTTHUMP00000201891 ELISA Kit; Putative binding protein 7a5 ELISA Kit; SH3 domain-containing protein 7a5 ELISA Kit; SH3BP4L ELISA Kit
  • 縮寫：
  • Uniprot No.：
  • 種屬：
    Homo sapiens (Human)
  • 樣本類型：
    serum, plasma, tissue homogenates, cell lysates
  • 檢測(cè)范圍：
    47 pg/mL-3000 pg/mL
  • 靈敏度：
    11.75 pg/mL
  • 反應(yīng)時(shí)間：
    1-5h
  • 樣本體積：
    50-100ul
  • 檢測(cè)波長(zhǎng)：
    450 nm
  • 研究領(lǐng)域：
    Cancer
  • 測(cè)定原理：
    quantitative
  • 測(cè)定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human MACC1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    　 Sample Serum(n=4)
    1:1 Average % 96
    Range % 92-101
    1:2 Average % 84
    Range % 80-88
    1:4 Average % 91
    Range % 85-95
    1:8 Average % 98
    Range % 94-102
  • 回收率：
    The recovery of human MACC1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 106 101-113
    EDTA plasma (n=4) 86 82-90
  • 標(biāo)準(zhǔn)曲線：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/ml OD1 OD2 Average Corrected
    3000 2.711 2.541 2.626 2.512
    1500 1.955 1.874 1.915 1.801
    750 1.044 1.105 1.075 0.961
    375 0.588 0.612 0.600 0.486
    187.5 0.353 0.340 0.347 0.233
    94 0.236 0.253 0.245 0.131
    47 0.178 0.169 0.174 0.060
    0 0.111 0.117 0.114 　
  • 數(shù)據(jù)處理：
  • 貨期：
    3-5 working days

產(chǎn)品評(píng)價(jià)

平均分:
5.0分 - 1 個(gè)評(píng)價(jià)

樣品類型：血清

樣品信息：人

稀釋比：1:100

產(chǎn)品評(píng)價(jià)： 我用Macc1（CSB-EL013298HU）ELISA kit檢測(cè)正常人與精神病患者血清中的MACC1，發(fā)現(xiàn)精神病患者血清中的MACC1顯著升高。該試劑盒真好用呀。

By 王老師

靶點(diǎn)詳情

  • 功能：
    Acts as a transcription activator for MET and as a key regulator of HGF-MET signaling. Promotes cell motility, proliferation and hepatocyte growth factor (HGF)-dependent scattering in vitro and tumor growth and metastasis in vivo.
  • 基因功能參考文獻(xiàn)：
    1. Expression levels of MACC1, CD44, Twist1, and KiSS-1 are related to duration of overall survival among patients with colonic adenocarcinoma. PMID: 30021598
    2. Authors validated that metastasis associated in colon cancer-1 (MACC1) is a novel target of miR-598 in GBM. Restoring MACC1 expression reversed the inhibitory effects of miR-598 overexpression on GBM cells. PMID: 29444745
    3. These results demonstrated that miR485 may perform its tumor suppressive function in cervical cancer by directly targeting MACC1 and inhibiting the Met/AKT signaling pathway. Therefore, the miR485/MACC1 axis may be a novel and effective therapeutic target in cervical cancer. PMID: 29916552
    4. MACC1 is an independent prognostic marker in patients with small invasive lung adenocarcinoma after complete surgical resection. Differential outcomes are associated with MACC1 expression level. PMID: 29630522
    5. MACC1 and c-Myc are highly expressed in serum and tumor tissues of EC patients. Both are correlated with TNM stage, primary infiltration, and lymph node or distal metastasis. PMID: 29984790
    6. The results of this study found that MACC1 protein expression in tumor tissue is significantly prognostic for shorter disease-free survival. PMID: 29678846
    7. miR-338-3p/MACC1/MAPK regulatory pathway play an important role in the progression of cervical cancer. PMID: 29243777
    8. this study found that upregulation of MACC1 in ESCC was associated with lymph node metastasis of patients, and MACC1 regulated ESCC cell proliferation, apoptosis, migration and invasion mainly through AMPK-ULK1 induced autophagy PMID: 28791376
    9. MACC1 overexpression is associated with poor survival rates, regional invasion and lymph-node metastasis [meta-analysis] PMID: 27542234
    10. MACC1 expression stratifies colon cancer patients with unfavorable pMMR status. Stage II colon cancer patients with pMMR/MACC1-low tumors have a similar favorable prognosis to those with dMMR with potential implications for the role of adjuvant therapy PMID: 28460000
    11. coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short overall survival PMID: 29700912
    12. YB-1 promoted lung adenocarcinoma growth and progression in vitro and in vivo through directly binding to the MACC1 promoter and enhancing MACC1/c-Met pathway. PMID: 28624808
    13. Serum metastasis-associated in colon cancer-1 (MACC1) levels were higher in breast cancer patients than patients with benign disease or healthy volunteers. PMID: 27793048
    14. restoration of MACC1 expression could abrogate the anti-metastatic effects of miR-944 on colorectal cancer (CRC)cells with enhanced cell migration and invasion. MACC1/Met/AKT signaling may be implicated with the function of miR-944 in CRC cells. Altogether, miR-944 potentially act as a prognostic predictor and a drug-target for CRC patients. PMID: 28498456
    15. Data suggest that the miR-497/MACC1 axis mediated the effect of XIST on GC cell growth. PMID: 27911852
    16. these findings highlight the pivotal role of miR-218 in various aspects of MACC1 expression regulation and MACC1-mediated colorectal cancer progression PMID: 27462788
    17. MACC1-induced tumor progression in colorectal cancer acts, at least in part, via the newly discovered MACC1/Nanog/Oct4 axis. PMID: 26758557
    18. Data indicate that OR3A4 upregulation contributes to metastasis and tumorigenesis in gastric cancer by regulating the activation of PDLIM2, MACC1, NTN4, and GNB2L1. PMID: 26863570
    19. H19 may regulate non-small cell lung cancer (NSCLC) metastasis through modulating cellular signaling pathway proteins related to cell proliferation and cell adhesion, including MACC1, EGFR, beta-catenin and ERK1/2. PMID: 27607135
    20. Metastasis-associated in colon cancer 1 is expressed at early stages of colorectal oncogenesis within the affected colonic tissue in colorectal cancer patient cohort. PMID: 27439755
    21. MACC1 is a key driver and prognostic biomarker for cancer progression and metastasis in a large variety of solid tumor types, particularly colorectal cancer (CRC). Data suggest that some small molecules with antineoplastic activity inhibit MACC1 transcription in CRC and prevent liver metastasis in CRC; lovastatin and rottlerin are the antineoplastic agents used here. PMID: 28570591
    22. MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers. PMID: 28649004
    23. High expression of MACC1 is associated with non-small cell lung cancer. PMID: 27832750
    24. MACC1 down-regulation suppresses endometrial carcinoma cell proliferation. PMID: 27991682
    25. SPON2 is a transcriptional target of the metastasis gene MACC1. SPON2 induces cell motility in vitro and CRC metastasis in mice. In patients, SPON2 serves as prognostic indicator for CRC metastasis and survival, and might represent a promising target for therapeutic approaches. PMID: 26686083
    26. High MACC1 expression is associated with Angiogenesis and recurrence in Gastric Cancer. PMID: 27280289
    27. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer. PMID: 27431311
    28. Data show that metastasis-associated in colon cancer-1 (MACC1) and monocarboxylate transporter 1 (MCT1) are highly expressed in gastric cancer indicating poor prognosis. PMID: 28235486
    29. A novel role of MACC1 in gastric cancer cell lipogenesis.MACC1 and FASN are positively correlated and responsible for the poor prognoses in gastric cancer patients. PMID: 28339092
    30. MACC1 is more frequently expressed in a poor prognosis phenotype of gastric cancer and acts as a promising prognostic prediction parameter for gastric cancer PMID: 27143263
    31. Results indicate that Nav 1.7 promotes GC progression through MACC1-mediated upregulation of NHE1. PMID: 27529686
    32. MACC1 gene (metastasis-associated in colon cancer 1) is upregulated in cancer stem cells both resistant and sensitive to chemotherapy PMID: 27917797
    33. MACC1 overexpression is associated with gastric cancer. PMID: 27793161
    34. High MACC1 expression is associated with colorectal cancer. PMID: 27492459
    35. Downregulation of MACC1 upregulates E-cadherin, N-cadherin and Vimentin in melanoma cell lines. PMID: 27488539
    36. MACC1 is essential for acetylcholine-induced gastric cancer cell invasion/migration and epithelial-mesenchymal transition PMID: 26919111
    37. Study demonstrated that suppression of MACC1 improves the chemosensitivity of cisplatin in epithelial ovarian cancer cells probably through regulation of the ERK1/2 signaling pathway and P-gp and its downstream apoptotic proteins. PMID: 26794135
    38. MACC1 was a specific target gene of miR-338-3p, which regulates malignant biological behaviors of glioma cells partly through directly silencing MACC1 expression. PMID: 26936749
    39. This study suggests that MACC1 is an independent prognostic factor in gastric adenocarcinoma and that the prognostic impact of MACC1 may be associated with MACC1 partners other than MET. PMID: 26719224
    40. Metastasis-associated in colon cancer-1 may have an important role in tumour development in adenoid cystic carcinoma. Metastasis-associated in colon cancer-1 is a potential biomarker for adenoid cystic carcinoma. PMID: 25640194
    41. downregulation of MACC1 expression could enhance cisplatin sensitivity and decrease drug resistance in SKOV- 3/DDP cells. PMID: 26681060
    42. Our findings suggest that MACC1 protein, as a valuable marker of cervical cancer prognosis, plays an important role in the progression of human cervical cancer cells. PMID: 26332389
    43. Our results suggest that rs975263 and rs4721888 polymorphisms in MACC1 are associated with the risk of breast cancer susceptibility and may be involved in the progression of breast cancer in Chinese women PMID: 26871844
    44. Conclude that the ability of proliferation and invasion in T24 cells can be inhibited by RNAi-targeting MACC1. PMID: 26339359
    45. the expression levels of MACC1 were significantly correlated with the biological processes underlying glioma cell proliferation, invasion and metastasis. PMID: 26043756
    46. In renal cell carcinoma, positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage. patients with higher MACC1 expression had a significantly lower disease-free rate PMID: 26097569
    47. conclusion, high MACC1 expression may serve as a prognostic biomarker to guide individualized management in clinical practice for digestive system neoplasms. PMID: 26090393
    48. MACC1 promotes vasculogenic mimicry in gastric cancer by regulating the HGF/c-Met-TWIST1/2 signaling pathway. PMID: 25895023
    49. MACC1 expression predicts survival outcome in colorectal cancer patients. PMID: 25884643
    50. These results suggested that MACC1 leads to a poor prognosis in HCC, partly by promoting proliferation via enhancement in glucose metabolism by HK2. PMID: 25738944

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Cytoplasm. Nucleus. Note=Mainly found in the cytoplasm in non-metastasizing tumors.
  • 組織特異性：
    Preferentially expressed in metastasizing tumors.
  • 數(shù)據(jù)庫(kù)鏈接：

    HGNC: 30215

    OMIM: 612646

    KEGG: hsa:346389

    STRING: 9606.ENSP00000328410

    UniGene: Hs.598388